HEI-3090

N/A

Report date: 2022/05/17 13:54:36
NME

Base Information

Drug NameHEI-3090
Drug Alias NameHEI-3090
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 7 activators
TargetsP2X purinoceptor 7
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentre Antoine Lacassagne
China Registration ClassN/A

Develop Information

Active CompaniesCentre Antoine Lacassagne
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A